Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cv Sciences Inc (CVSI)

Cv Sciences Inc (CVSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cv Sciences Inc 9530 Padgett Street Suite 107 San Diego CA 92126 USA

www.cvsciences.com Employees: 43 P: 866-290-2157

Description:

CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,427
Enterprise Value, $K 7,357
Shares Outstanding, K 184,794
Annual Sales, $ 16,000 K
Annual Net Income, $ 3,100 K
Last Quarter Sales, $ 3,950 K
Last Quarter Net Income, $ -580 K
EBIT, $ -2,530 K
EBITDA, $ -2,180 K
60-Month Beta 0.59
% of Insider Shareholders 1.30%
% of Institutional Shareholders 0.00%
Float, K 182,392
% Float 98.70%
Short Volume Ratio 0.23

Growth:

1-Year Return 32.20%
3-Year Return -77.93%
5-Year Return -97.06%
5-Year Revenue Growth -66.83%
5-Year Earnings Growth -77.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 08/13/24
Next Earnings Date 11/14/24 [BMO]
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year 100.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CVSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -89.87%
Return-on-Assets % -27.94%
Profit Margin % 19.38%
Debt/Equity 0.01
Price/Sales 0.53
Price/Cash Flow 2.18
Price/Book 3.32
Book Value/Share 0.01
Interest Coverage -1.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar